Get the Stockscreener App
57.22
0.16%
0.08
Iradimed Corp stock is traded at $57.22, with a volume of 6,181.
It is up +0.16% in the last 24 hours and down -5.14% over the past month.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
See More
Previous Close:
$57.14
Open:
$57.58
24h Volume:
6,181
Relative Volume:
0.15
Market Cap:
$724.16M
Revenue:
$69.48M
Net Income/Loss:
$18.64M
P/E Ratio:
39.19
EPS:
1.46
Net Cash Flow:
$13.01M
1W Performance:
+3.62%
1M Performance:
-5.14%
6M Performance:
+27.32%
1Y Performance:
+32.14%
1-Day Range:
$56.97
$58.02
1-Week Range:
$55.17
$58.02
52-Week Range:
$40.18
$63.29
Iradimed Corp Stock (IRMD) Company Profile
Name
Iradimed Corp
Sector
Industry
Phone
(407) 677-8022
Address
1025 WILLA SPRINGS DR., WINTER SPRINGS
Compare IRMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
57.31 | 724.16M | 69.48M | 18.64M | 13.01M | 1.46 |
|
ABT
Abbott Laboratories
|
134.41 | 230.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.35 | 155.49B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
385.49 | 147.45B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.59 | 112.85B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.02 | 44.06B | 5.72B | 4.17B | 490.10M | 6.97 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-23 | Initiated | Lake Street | Buy |
| Oct-31-17 | Resumed | ROTH Capital | Buy |
| Oct-05-16 | Downgrade | ROTH Capital | Buy → Neutral |
| Nov-02-15 | Reiterated | ROTH Capital | Buy |
| Jul-30-15 | Reiterated | ROTH Capital | Buy |
| Jun-16-15 | Reiterated | ROTH Capital | Buy |
| Jan-12-15 | Reiterated | ROTH Capital | Buy |
| Dec-23-14 | Reiterated | ROTH Capital | Buy |
View All
Iradimed Corp Stock (IRMD) Latest News
Iradimed (NASDAQ:IRMD) Raised to Strong-Buy at StockNews.com - Defense World
Iradimed (NASDAQ:IRMD) Given Buy Rating at Roth Mkm - MarketBeat
Iradimed (NASDAQ:IRMD) Issues Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat
Iradimed (NASDAQ:IRMD) Updates FY 2025 Earnings Guidance - MarketBeat
Iradimed (NASDAQ:IRMD) Issues Q1 2025 Earnings Guidance - MarketBeat
Iradimed Corporation (NASDAQ:IRMD) Raises Dividend to $0.17 Per Share - MarketBeat
Iradimed (NASDAQ:IRMD) Shares Gap Down on Disappointing Earnings - MarketBeat
IRadimed Corporation (NASDAQ:IRMD) Q4 2024 Earnings Call Transcript - Insider Monkey
Iradimed’s (IRMD) Buy Rating Reiterated at Roth Mkm - Defense World
Iradimed Corp: Record Revenue and Positive Outlook - TipRanks
Iradimed (NASDAQ:IRMD) Downgraded to "Buy" Rating by StockNews.com - MarketBeat
Iradimed (NASDAQ:IRMD) Cut to Buy at StockNews.com - Armenian Reporter
Iradimed Co earnings beat by $0.04, revenue topped estimates - Investing.com Canada
iRadimed Corp (IRMD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Shifts - Yahoo Finance UK
iRadimed Corp (IRMD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Shifts By GuruFocus - Investing.com Canada
IRADIMED CORPORATION Reports Record Revenue Growth - TipRanks
Earnings call transcript: Iradimed Co Q4 2024 beats EPS forecasts, stock drops - Investing.com Nigeria
IRadimed projects $78M-$82M revenue for FY2025 amid strong pump demand and FDA clearance timelines - MSN
IRadimed: Q4 Earnings Snapshot - Thehour.com
IRADIMED Earnings Results: $IRMD Reports Quarterly Earnings - Nasdaq
IRadimed: Q4 Earnings Snapshot -February 13, 2025 at 08:41 am EST - Marketscreener.com
IRADIMED CORPORATION Announces Fourth Quarter and Full Year 2024 Financial Results - TradingView
IRADIMED Q4 Earnings: Record Revenue Growth, 13% Dividend Boost, Strong 2025 Outlook | IRMD Stock News - StockTitan
StockNews.com Downgrades Iradimed (NASDAQ:IRMD) to Buy - Defense World
Iradimed (NASDAQ:IRMD) Sets New 52-Week HighStill a Buy? - MarketBeat
Iradimed (IRMD) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Copeland Capital Management LLC Acquires 53,138 Shares of Iradimed Corporation (NASDAQ:IRMD) - MarketBeat
Iradimed Corporation (NASDAQ:IRMD) Sees Significant Growth in Short Interest - MarketBeat
Iradimed (NASDAQ:IRMD) Downgraded by StockNews.com to Buy - Defense World
SG Americas Securities LLC Has $363,000 Stock Holdings in Iradimed Corporation (NASDAQ:IRMD) - Defense World
Iradimed (NASDAQ:IRMD) Upgraded by StockNews.com to "Strong-Buy" Rating - MarketBeat
Iradimed (NASDAQ:IRMD) Hits New 12-Month HighShould You Buy? - MarketBeat
IRADIMED's Crucial Year-End Results: What Q4 2024 Earnings Call Will Reveal - StockTitan
Iradimed (NASDAQ:IRMD) Stock Rating Upgraded by StockNews.com - Defense World
IRADIMED's (NASDAQ:IRMD) investors will be pleased with their solid 156% return over the last five years - Yahoo Finance
IRadimed Corp. to Host Earnings Call - ACCESS Newswire
JPMorgan Chase & Co. Increases Stake in Iradimed Corporation (NASDAQ:IRMD) - MarketBeat
JPMorgan Chase & Co. Buys 12,051 Shares of Iradimed Corporation (NASDAQ:IRMD) - Defense World
Iradimed (NASDAQ:IRMD) Reaches New 52-Week HighHere's Why - MarketBeat
Iradimed Corporation (NASDAQ:IRMD) Sees Large Increase in Short Interest - MarketBeat
Iradimed (NASDAQ:IRMD) Reaches New 12-Month HighTime to Buy? - MarketBeat
Iradimed Corp Stock (IRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.56%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):